Physician profile
Edward Finger
NPI 1134235633
$2,627.20
in general payments reported to CMS, 2019-2025
15 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $557 · 2020: $96.63 · 2021: $454 · 2022: $551 · 2023: $323 · 2024: $532 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $969.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $555.00 | 2019-2023 | Krystexxa |
| Amgen INC. | $239.96 | 2024-2025 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $236.81 | 2022-2024 | Nuzyra |
| Organogenesis INC. | $224.87 | 2019-2021 | |
| Smith+Nephew, INC. | $210.18 | 2021-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $189.78 | 2019-2020 | |
| Tactile Systems Technology INC | $147.84 | 2024 | Entre Plus, Flexitouch Plus |
| Next Science LLC | $138.99 | 2024 | Surgx, Xperience, Blastx |
| Nevro Corp. | $135.26 | 2022 | |
| Kerecis Limited | $114.59 | 2022 | |
| Melinta Therapeutics, LLC | $113.14 | 2019 | |
| Boston Scientific Corporation | $110.55 | 2023 | |
| Averitas Pharma INC. | $104.35 | 2023 | Qutenza |
| Advanced Oxygen Therapy INC. | $94.79 | 2021 | |
| Merck Sharp & Dohme LLC | $11.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Finger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.